These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10233668)

  • 1. Stromelysin-3 (ST-3): immunohistochemical characterization of the matrix metalloproteinase (MMP)-11 in benign and malignant skin tumours and other skin disorders.
    Thewes M; Worret WI; Engst R; Ring J
    Clin Exp Dermatol; 1999 Mar; 24(2):122-6. PubMed ID: 10233668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers.
    Kerkelä E; Ala-aho R; Lohi J; Grénman R; M-Kähäri V; Saarialho-Kere U
    Br J Cancer; 2001 Mar; 84(5):659-69. PubMed ID: 11237387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of stromelysin-3 in basal cell carcinomas.
    Majmudar G; Nelson BR; Jensen TC; Voorhees JJ; Johnson TM
    Mol Carcinog; 1994 Jan; 9(1):17-23. PubMed ID: 8297480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human collagenase-3 is expressed in malignant squamous epithelium of the skin.
    Airola K; Johansson N; Kariniemi AL; Kähäri VM; Saarialho-Kere UK
    J Invest Dermatol; 1997 Aug; 109(2):225-31. PubMed ID: 9242512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromelysin-3: a potent marker for histopathologic differentiation between desmoplastic trichoepithelioma and morphealike basal cell carcinoma.
    Thewes M; Worret WI; Engst R; Ring J
    Am J Dermatopathol; 1998 Apr; 20(2):140-2. PubMed ID: 9557781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of stromelysin 3 in the stromal elements of human basal cell carcinoma.
    Wagner SN; Ruhri C; Kunth K; Holecek BU; Goos M; Höfler H; Atkinson MJ
    Diagn Mol Pathol; 1992 Sep; 1(3):200-5. PubMed ID: 1342967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of stromelysin 3 in basal cell carcinomas.
    Cribier B; Noacco G; Peltre B; Grosshans E
    Eur J Dermatol; 2001; 11(6):530-3. PubMed ID: 11701402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of stromelysin 3 in keratoarcanthoma and squamous cell carcinoma.
    Asch PH; Basset P; Roos M; Grosshans E; Bellocq JP; Cribier B
    Am J Dermatopathol; 1999 Apr; 21(2):146-50. PubMed ID: 10218674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromelysin-3 mRNA associated with myofibroblasts is overexpressed in aggressive basal cell carcinoma and in dermatofibroma but not in dermatofibrosarcoma.
    Undén AB; Sandstedt B; Bruce K; Hedblad M; Stahle-Bäckdahl M
    J Invest Dermatol; 1996 Aug; 107(2):147-53. PubMed ID: 8757754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of matrix metalloproteinases 1, 2, 9, and 14 in dermatofibrosarcoma protuberans and common fibrous histiocytoma (dermatofibroma).
    Weinrach DM; Wang KL; Wiley EL; Laskin WB
    Arch Pathol Lab Med; 2004 Oct; 128(10):1136-41. PubMed ID: 15387709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase expression in malignant melanomas: tumor-extracellular matrix interactions in invasion and metastasis.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2001; 15(1):57-64. PubMed ID: 11286131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases in skin.
    Kähäri VM; Saarialho-Kere U
    Exp Dermatol; 1997 Oct; 6(5):199-213. PubMed ID: 9450622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A switch from stromal to tumor cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression.
    Wright JH; McDonnell S; Portella G; Bowden GT; Balmain A; Matrisian LM
    Mol Carcinog; 1994 Aug; 10(4):207-15. PubMed ID: 8068181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions.
    Bolon I; Brambilla E; Vandenbunder B; Robert C; Lantuejoul S; Brambilla C
    Lab Invest; 1996 Jul; 75(1):1-13. PubMed ID: 8683934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans.
    Kossakowska AE; Huchcroft SA; Urbanski SJ; Edwards DR
    Br J Cancer; 1996 Jun; 73(11):1401-8. PubMed ID: 8645587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix-degrading metalloproteinases in tumor progression.
    Matrisian LM; Wright J; Newell K; Witty JP
    Princess Takamatsu Symp; 1994; 24():152-61. PubMed ID: 8983072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer.
    Sharma R; Chattopadhyay TK; Mathur M; Ralhan R
    Oncology; 2004; 67(3-4):300-9. PubMed ID: 15557792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma glutamyl transpeptidase expression in foetal skin, inflammatory dermatoses and cutaneous neoplasia.
    Groves RW; Fracchia JN; MacDonald DM
    Br J Dermatol; 1991 Jul; 125(1):1-5. PubMed ID: 1678620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
    Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
    Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.